Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy April 2024 173 - Subject
- Language
- ISSN
- 0753-3322